Pseudomonas aeruginosa bacteremia among liver transplant recipients

• Main Authors: Liu TH, Zhang YZ, Wan QQ
• Format: Article
• Language: English
• Published: Dove Medical Press 2018-11-01
• Series: Infection and Drug Resistance
• Subjects: antimicrobial resistance; combination therapy; liver transplantation
• Online Access: https://www.dovepress.com/pseudomonas-aeruginosa-bacteremia-among-liver-transplant-recipients-peer-reviewed-article-IDR

Taohua Liu,1 Yuezhong Zhang,1 Qiquan Wan2 1Xiangya School of Medicine, Central South University, Changsha 410083, China; 2Department of Transplant Surgery, The Third Xiangya Hospital, Central South University, Changsha 410013, China Abstract: Pseudomonas aeruginosa bacteremia remains as a life-threatening complication after liver transplantation (LT) and is intractable because of the high rate of drug resistance to commonly used antibiotics. To better understand the characteristics of this postoperative complication, PubMed and Embase searches as well as reference mining was done for relevant literature from the start of the databases through August 2018. Among LT recipients, the incidence of P. aeruginosa bacteremia ranged from 0.5% to 14.4% and mortality rates were up to 40%. Approximately 35% of all episodes of bloodstream infections (BSIs) were P. aeruginosa bacteremia, of which 47% were multidrug resistant and 63% were extensively drug resistant. Several factors are known to affect the mortality of LT recipients with P. aeruginosa bacteremia, including hypotension, mechanical ventilation, and increasing severity of illness. In LT recipients with P. aeruginosa bacteremia, alteration in DNA gyrase A genes and overexpression of proteins involved in efflux systems, namely the expression of KPC-2-type carbapenemase, NDM-1, and VIM-2-type MBL, contribute to the high resistance of P. aeruginosa to a wide variety of antibiotics. Because of complicated mechanisms of drug resistance, P. aeruginosa causes high morbidity and mortality in bacteremic LT patients. Consequently, early detection and treatment with adequate early targeted coverage for P. aeruginosa BSI are of paramount importance in the early posttransplantation period to obtain a better prognosis for LT patients. Keywords: antimicrobial resistance, morbidity and mortality, risk factor, solid organ transplantation, liver transplantation